In addition, as a supportive secondary endpoint, 77% of patients taking semaglutide (Wegovy) experienced a BMI reduction of greater than or equal to 5%, compared with 20% taking placebo. Study investigators Pediatric obesity In the U.S., an estimated 1 in 5 adolescents between the ages of 12 and 19 have the disease of obesity
Saxenda should not be used in children under 12 because it's not safe and effective in this age group
Jabby's specialized features provide everything you need to monitor your progress, manage your treatment, and achieve your health goals
Some other impressive facts to consider
The Weight Loss by Hers program is a holistic service that provides tools to help you better manage your weight with medical prescriptions as well as nutrition support, meal replacement options, activity goals and more
These examples showcase the promise of this new enzyme class